*  Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation | RTI
As new oral anticoagulants are available, barriers to optimal use of oral anticoagulation therapy warrant consideration by ... Oral anticoagulant therapy is the mainstay of stroke prevention in patients with atrial fibrillation; it is highly effective at ... Oral anticoagulant therapy is the mainstay of stroke prevention in patients with atrial fibrillation; it is highly effective at ... As new oral anticoagulants are available, barriers to optimal use of oral anticoagulation therapy warrant consideration by ...
  https://www.rti.org/publication/review-challenges-optimizing-oral-anticoagulation-therapy-stroke-prevention-atrial
*  Timeline: FDA approval of NOACs. FDA-approved oral anticoagulants. FDA-approved oral anticoagulants. Stroke risk reductions:...
BCPS Pharmacology Conference April 2016 Objectives Compare current FDA-approved oral anticoagulants Understand practical issues ... Anticoagulant Treatment for Deep Venous Thrombosis Direct Oral Anticoagulants (NOACs) Anticoagulant Treatment for Deep Venous ... New Oral Anticoagulants for VTE, A-fib, and ACS New Oral Anticoagulants for VTE, A-fib, and ACS KCUMB Fall CME 2014 September ... New Oral Anticoagulants. How safe are they outside the trials? New Oral Anticoagulants How safe are they outside the trials? ...
  http://docplayer.net/18162267-Timeline-fda-approval-of-noacs-fda-approved-oral-anticoagulants-fda-approved-oral-anticoagulants-stroke-risk-reductions-afib-rcts-4-8-2016.html
*  Principles of Antithrombotic Therapy | Williams Hematology, 9e | AccessHemOnc | McGraw-Hill Medical
For many decades, warfarin, which acts by inhibiting vitamin K action, was the only oral anticoagulant available. Vitamin K ... Antithrombotic drugs are among the most commonly used drugs in medicine and are generally separated into anticoagulants, ... Several parenteral direct thrombin inhibitors have excellent anticoagulant action and offer an alternative to heparins. A ... The introduction of novel targeted oral anticoagulants has changed the landscape of anticoagulation. Rivaroxaban, apixaban, and ...
  http://hemonc.mhmedical.com/content.aspx?bookid=1581§ionid=94302933
*  ORAL ANTICOAGULATION RELATED INTRACEREBRAL HEMORRHAGE: MORE QUESTIONS THAN ANSWERS
Intracranial hemorrhage (ICH) is the most feared and devastating complication of oral anticoagulant therapy. When an ICH occurs ... OBJECTIVE: Dabigatran is a novel target specific oral anticoagulant for stroke prevention in non valvular atrial fibrillation. ... One research paper shows that anticoagulants prevent stroke in patients with atrial fibrillation. Therapy with either aspirin ... The rationale of conservative therapy with repeated sympathetic procain blocks and anticoagulants and its indications are ...
  http://connection.ebscohost.com/c/articles/84270522/oral-anticoagulation-related-intracerebral-hemorrhage-more-questions-than-answers
*  Journals-Paper Information - American Institute of Science
In spite of the beneficial effect of warfarin as a blood anticoagulant drug, high anticoagulation may lead to bleeding and low ... The participants' knowledge about different aspects of warfarin as an anticoagulant was assessed before and after ... Management of Dental Extractions in Patients taking Warfarin as Anticoagulant Treatment: A Systematic Review, j can dent assoc ... of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a ...
  http://www.aiscience.org/journal/paperInfo/ijpmr?paperId=3553
*  Plus it
Anticoagulant-related ICH in patients with anticoagulation therapy is approximately 0.2% per year occurred. There is no study ... As the use of vitamin K antagonists is increased, the risk of anticoagulant-related intracranial hemorrhage(ICH) is emphasized ... about anticoagulant-related ICH in Korea. We retrospectively reviewed the records of ICH patients at Soonchunhyang University ...
  http://erj.ersjournals.com/content/44/Suppl_58/P2401
*  NWMIC Medicines FAQ. New oral anticoagulants (NOACs) and management of dental patients - Dabigatran, rivaroxaban and apixaban. ...
NWMIC Medicines FAQ New oral anticoagulants (NOACs) and management of dental patients - Date prepared: May 2013, updated ... Introducing the Direct Oral Anticoagulants into Clinical Practice Rory McSorley, Anticoagulant Pharmacist Anticoagulant Service ... New Oral Anticoagulants. How safe are they outside the trials? New Oral Anticoagulants How safe are they outside the trials? ... Traditional anticoagulants TEGH Family Practice Clinic Day April 4, 03 Use of Anticoagulants in 03: What s New (and What Isn t ...
  http://docplayer.net/1461743-Nwmic-medicines-faq-new-oral-anticoagulants-noacs-and-management-of-dental-patients-dabigatran-rivaroxaban-and-apixaban.html
*  Coagulation assessment with the new generation of oral anticoagulants | Emergency Medicine Journal
Non-warfarin oral anticoagulants (NOACs, formerly 'novel' oral anticoagulants and now sometimes referred to as non-vitamin K ... Why assess anticoagulant activity?. When a patient presents in the ED, and is known or suspected to be on OAC therapy, it is ... Which test to use to measure the anticoagulant effect of rivaroxaban: the anti-factor Xa assay. J Thromb Haemost 2013;11:579-80 ... National trends in oral anticoagulant use in the United States, 2007 to 2011. Circ Cardiovasc Qual Outcomes 2012;5:615-21. doi: ...
  http://emj.bmj.com/content/early/2015/05/17/emermed-2015-204891
*  ESC guide on new oral anticoagulant drugs - Healthcanal.com : Healthcanal.com
Sophia Antipolis A practical guide on the use of the new oral anticoagulants (NOACs) has been produced by the European Heart ... The clinical situations include how to initiate and monitor NOAC use, how to measure the anticoagulant effect if needed in ... But Professor Heidbuchel said: "Compliance is very important for the novel anticoagulant drugs because they have a very short ... Professor Heidbuchel said: "We have learned from the big trials that these moments of transitioning from one anticoagulant to ...
  https://www.healthcanal.com/blood-heart-circulation/38081-esc-guide-on-new-oral-anticoagulant-drugs.html
*  3/25/14. To Clot or Not What s New In Anticoagulation? Clotting Cascade. Anticoagulant drug targets. Anita Ralstin, MS CNS CNP....
MS CNS CNP 1 Clotting Cascade 2 Anticoagulant drug targets Heparin XI VIII IX V X VII LMWH II Warfarin Fibrin clot 1 Who Needs ... New Oral Anticoagulants. How safe are they outside the trials? New Oral Anticoagulants How safe are they outside the trials? ... Traditional anticoagulants TEGH Family Practice Clinic Day April 4, 03 Use of Anticoagulants in 03: What s New (and What Isn t ... New Oral Anticoagulants Disclosures The New Oral Anticoagulants: Are they better than Warfarin? Alan P. Agins, Ph.D. does not ...
  http://docplayer.net/1461886-3-25-14-to-clot-or-not-what-s-new-in-anticoagulation-clotting-cascade-anticoagulant-drug-targets-anita-ralstin-ms-cns-cnp-heparin.html
*  D-Dimer Guided Oral Anticoagulant Treatment (OAT) - Full Text View - ClinicalTrials.gov
D-Dimer Guided Oral Anticoagulant Treatment (OAT) (DDOAT2006). The recruitment status of this study is unknown. The completion ... Active Comparator: oral anticoagulants Experimental intervention: Extension of OAT in VTE patients showing high plasma levels ... Anticoagulants. Phenprocoumon. Fibrin fragment D. Antifibrinolytic Agents. Fibrin Modulating Agents. Molecular Mechanisms of ... secondary prophylaxis using oral anticoagulant treatment (OAT). higher risk of recurrence in patients showing increased levels ...
  https://clinicaltrials.gov/ct2/show/NCT00895505?recr=Open&intr=%22Anticoagulants%22&rank=13
*  Indications for anticoagulant and antiplatelet combined therapy | The BMJ
In most patients with independent indications for both antiplatelet and oral anticoagulant therapy the pathophysiology will ... Antiplatelet drugs and oral anticoagulants are examples of antithrombotic medications and are among the most commonly ... Patients can develop independent indications for antiplatelet and oral anticoagulant therapy, but in most cases the ... A visual summary of approaches for combining anticoagulants and antiplatelets, along with clinical scenario examples ...
  http://www.bmj.com/content/359/bmj.j3782.full
*  The anticoagulant properties of a modified form of protein S. - Semantic Scholar
PS preincubated with the monoclonal antibody, acquired similar anticoagulant properties. These results suggest that the ... had significant anticoagulant activity in the absence of APC when measured in a factor Xa recalcification time. Using SDS-PAGE ... is a vitamin K-dependent anticoagulant that acts as a cofactor to activated protein C (APC). To date PS has not been shown to ... These observations suggest that PS can be modified in vitro to a protein with APC-independent anticoagulant activity and raise ...
  https://www.semanticscholar.org/paper/The-anticoagulant-properties-of-a-modified-form-of-Mitchell-Kelemen/2f8a55677ac497242f72d6b290e1ae9a0c72a97c
*  Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation - Full Text View - ClinicalTrials.gov
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. ... to 6 weeks after DES implantation is associated with improved clinical outcomes in patients on ASA and an oral anticoagulant. ... of a Six-week Versus a Six-month Clopidogrel Treatment Regimen in Patients With Concomitant Aspirin and Oral Anticoagulant ... of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant ...
  https://clinicaltrials.gov/ct2/show/NCT00776633?term=atrial+fibrillation&lup_s=08%2F15%2F2014&lup_d=14&show_rss=Y&sel_rss=mod14
*  Papers with the keyword use of rivaroxaban in children | Read by QxMD
The use of anticoagulants in neonates is increasing because of the medical advances improving the long-term survival of very ... These oral anticoagulants are administered at fixed daily doses, without the need for laboratory-guided adjustments. There are ... The new anticoagulants, both parenteral such as argatroban, bivalirudin and fondaparinux and oral such as dabigatran and ... Novel oral anticoagulants offer equivalent or improved therapeutic profiles compared with warfarin, with less risk of bleeding ...
  https://www.readbyqxmd.com/keyword/43230
*  Dr. Wes: Coumadin Beats Aspirin+Plavix
Once again, the anticoagulant warfarin (Coumadin) demonstrated clear superiority to even Aspirin and clopidogrel (Plavix) ...
  http://drwes.blogspot.com/2006/06/coumadin-beats-aspirinplavix.html
*  Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex ConcentrateClinical Perspective | Circulation
... are the most extensively evaluated novel anticoagulant agents. Both anticoagulants have little interaction with food or drugs ... thereby potentially bypassing the anticoagulant effect of both drugs. The assessment of the reversal of the anticoagulant ... The anticoagulant effect of dabigatran was monitored by the aPTT, lag time of the ETP, TT, and ECT because these assays seemed ... Not all PCCs contain similar levels of anticoagulants protein C and S.21 More protein C and S may lead to less thrombin ...
  http://circ.ahajournals.org/content/124/14/1573
*  Newer anticoagulants? | DailyStrength
I will be retested for lupus anticoagulant in a few months. Ive been on eliquis since it happened, and I'm worried that if I do ... After having a pe, I will be retested for lupus anticoagulant in a few months. Ive been on eliquis since it happened, and I'm ... When I was still on Eliquis, I asked my hematologist what would happen if my lupus anticoagulant test came back positive, and ... I asked her why, and she said that all the newest studies are trending toward the newer anticoagulants - even under those ...
  https://www.dailystrength.org/group/antiphospholipid-syndrome/discussion/newer-anticoagulants
*  New Anticoagulants | Circulation
New Anticoagulants. The new parenteral and oral anticoagulants are discussed separately. With each agent, the pharmacology is ... Classification of established anticoagulants and new anticoagulants that were recently licensed for use or are in advanced ... New Parenteral Anticoagulants. The pharmacological characteristics of the new parenteral anticoagulants that are in advanced ... Potential Advantages of New Anticoagulants. Although the need for new parenteral anticoagulants is less pressing than that for ...
  http://circ.ahajournals.org/content/121/13/1523
*  Anticoagulants for Alzheimer's? | ALZFORUM
Significantly, this drug is used as an anticoagulant in humans. So epidemiological data could reveal a protective effect ... Far-fetched? Luigi Bergamaschini and colleagues have already demonstrated that anticoagulants such as heparin can attenuate the ...
  http://www.alzforum.org/news/research-news/anticoagulants-alzheimers?id=1007
*  Anticoagulants in Myocardial Infarction | The BMJ
Anticoagulants in Myocardial Infarction. Br Med J 1953; 1 doi: https://doi.org/10.1136/bmj.1.4819.1109-b (Published 16 May 1953 ...
  http://www.bmj.com/content/1/4819/1109.3/submit-a-rapid-response
*  Anticoagulants in Coronary Thrombosis | The BMJ
Anticoagulants in Coronary Thrombosis. Br Med J 1947; 2 doi: https://doi.org/10.1136/bmj.2.4535.929-c (Published 06 December ...
  http://www.bmj.com/content/2/4535/929.4
*  Anticoagulants in Rheumatic Heart Disease | The BMJ
Anticoagulants in Rheumatic Heart Disease. Br Med J 1964; 2 doi: https://doi.org/10.1136/bmj.2.5400.55-a (Published 04 July ...
  http://www.bmj.com/content/2/5400/55.2
*  Heart-and-Stroke-Encyclopedia - anticoagulants
anticoagulants Anticoagulants are drugs that decrease the ability of the blood to clot, or coagulate. Also called blood ... Anticoagulants do not dissolve clots but may prevent existing clots from becoming larger and causing more serious problems. ... Common anticoagulant drugs are heparin, warfarin, rivaroxaban, apixaban, edoxaban and dabigatran.. Related: Cardiac Medications ...
  http://www.heart.org/HEARTORG/Encyclopedia/Heart-and-Stroke-Encyclopedia_UCM_445084_ContentIndex.jsp?title=anticoagulants
*  Mitral Annular Calcification Medication: Antiplatelet agents, Anticoagulants
Anticoagulants. Class Summary. Anticoagulants reduce the synthesis of active clotting factors and have been reported to be ...
  https://emedicine.medscape.com/article/1967024-medication